0001827506-24-000063.txt : 20240627 0001827506-24-000063.hdr.sgml : 20240627 20240627081228 ACCESSION NUMBER: 0001827506-24-000063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240625 FILED AS OF DATE: 20240627 DATE AS OF CHANGE: 20240627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robinson Ryan F. CENTRAL INDEX KEY: 0001997834 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40384 FILM NUMBER: 241075419 MAIL ADDRESS: STREET 1: C/O TOURMALINE BIO, INC. STREET 2: 27 WEST 24TH STREET, SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tourmaline Bio, Inc. CENTRAL INDEX KEY: 0001827506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 WEST 24TH STREET STREET 2: SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 646-481-9832 MAIL ADDRESS: STREET 1: 27 WEST 24TH STREET STREET 2: SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: Talaris Therapeutics, Inc. DATE OF NAME CHANGE: 20201007 4 1 wk-form4_1719490341.xml FORM 4 X0508 4 2024-06-25 0 0001827506 Tourmaline Bio, Inc. TRML 0001997834 Robinson Ryan F. C/O TOURMALINE BIO, INC. 27 WEST 24TH STREET, SUITE 702 NEW YORK NY 10010 0 1 0 0 Chief Financial Officer 0 Employee Stock Option (Right to Buy) 14.21 2024-06-25 4 A 0 76400 0 A 2034-06-24 Common Stock 76400 76400 D The shares subject to the option vest as to 25% of the shares on October 18, 2024 with the remainder vesting in 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date. /s/ Brad Middlekauff, Attorney-in-Fact 2024-06-27